Central Mechanisms of Chronic Pain and Fatigue Subtitle: Functional Imaging of Brain and Spinal Cord

Last updated: January 22, 2025
Sponsor: University of Florida
Overall Status: Completed

Phase

N/A

Condition

Pain

Pain (Pediatric)

Fibromyalgia

Treatment

functional magnetic resonance imaging for Brain Neuroimaging

A Peltier for Sensory testing

fMRI for Spinal Cord Neuroimaging

Clinical Study ID

NCT03075254
IRB201602417 -N-A
  • Ages 18-70
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Chronic pain and fatigue are characterized by peripheral and central mechanisms including low pain thresholds, temporal summation, peripheral and central sensitization. This application will focus on central factors of chronic pain and fatigue. Functional brain imaging will be used to characterized brain and spinal cord abnormalities that contribute to the mechanisms of these disorders.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • diagnosis of FM will require a history of chronic widespread pain as well as thepresence of at least eleven out of eighteen paired tender points.

  • diagnosis of ME/CFS will require a history of chronic fatigue persisting orrelapsing for more than 6 months as well as the presence of at least four out ofeight designated symptoms.

  • willing to reduce anti-depressants to low levels like amitriptyline 10 mg/day,trazodone 50 mg/day, citalopram 20 mg/day, for at least five half-lives of themedication.

Exclusion

Exclusion Criteria:

  • Patients unwilling or unable to discontinue or modify analgesics, hypnotics,anxiolytics, or anti-depressants during the study period will be excluded from thistrial.

Study Design

Total Participants: 197
Treatment Group(s): 3
Primary Treatment: functional magnetic resonance imaging for Brain Neuroimaging
Phase:
Study Start date:
March 15, 2017
Estimated Completion Date:
October 29, 2024

Study Description

Chronic fatigue (ME/CFS) and fibromyalgia syndrome (FM) are a chronic musculoskeletal pain disorder that predominantly afflicts women. Frequently associated insomnia, cognitive abnormalities, and fatigue may lead to early disability. No consistent soft tissue abnormalities have been identified so far in these patients. The cause of these disorders is unknown, no highly effective treatment is available and the current methods of diagnosis are imprecise and unreliable. The Investigators previously used quantitative sensory testing to improve upon diagnoses of these disorders by supplementing the current procedure of manipulating defined pressure points by hand and noting the presence or absence of pain. The quantitative methods of evaluation involve repetitive application of brief, non-injurious thermal/mechanical stimulation that normally produces a moderate degree of temporal summation of sensation intensity. The patients and normal control subjects will verbally rate the magnitude of late sensations elicited by each stimulus, using a numerical scale. Chronic pain in these patients results, at least partially, from exaggerated activation of central N-methyl-D-aspartate (NMDA) receptors as a result of enhanced input from unmyelinated peripheral afferent nerve fibers supplying deep tissues. Temporal summation of second pain can lead to central sensitization with subsequent signs of hyperalgesia and allodynia. Functional brain imaging of ME/CFS and FM patients, as proposed in this study, will be used to document their ratings of repetitive experimental stimuli and the resulting pain augmentation. Successful completion of this study will provide a new method for the evaluation of chronic pain/fatigue mechanism and their response to therapy.

Connect with a study center

  • University of Florida

    Gainesville, Florida 32611
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.